2020
DOI: 10.3390/jcm9020314
|View full text |Cite
|
Sign up to set email alerts
|

Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease

Abstract: Nonalcoholic liver disease (NAFLD) is manifested with a wide spectrum of clinical symptoms and is closely associated with the metabolic syndrome, inflammation, and mitochondrial dysfunction. Although the mechanism of mitochondrial dysfunction in NAFLD is still not fully elucidated, multiple studies have demonstrated evidence of molecular, biochemical, and biophysical mitochondrial abnormalities in NAFLD. Given the association between NAFLD and mitochondrial dysfunction, the aim of this study is to analyze circ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
7
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 42 publications
1
7
0
Order By: Relevance
“…Our data from targeted quantification that showed higher plasma TCA cycle intermediary metabolites were similar to previous reports on untargeted metabolomics in patients with AH and targeted metabolomics in patients with nonalcoholic fatty liver disease. 31,46 Interestingly, we noted lower concentrations of TCA cycle intermediary metabolites in PBMC from AH compared to HC. It is not clear if these responses are mechanistically linked to mitochondrial oxidative dysfunction in PBMC in AH.…”
Section: Discussionmentioning
confidence: 67%
See 1 more Smart Citation
“…Our data from targeted quantification that showed higher plasma TCA cycle intermediary metabolites were similar to previous reports on untargeted metabolomics in patients with AH and targeted metabolomics in patients with nonalcoholic fatty liver disease. 31,46 Interestingly, we noted lower concentrations of TCA cycle intermediary metabolites in PBMC from AH compared to HC. It is not clear if these responses are mechanistically linked to mitochondrial oxidative dysfunction in PBMC in AH.…”
Section: Discussionmentioning
confidence: 67%
“…Intermediary metabolites in plasma and PBMC were quantified as previously described 25,31 . Plasma for these analyses were collected from EDTA coated tubes due to dilution with Ficoll and CPT methods.…”
Section: Methodsmentioning
confidence: 99%
“…Recently, studies on patients with hypothalamic-pituitary involvement after craniopharyngioma have found that the prevalence of NAFLD in children is approximately 3%–10%, while the incidence of NAFLD caused by hypothalamic-pituitary damage after craniopharyngioma has increased to approximately 50%[ 11 , 12 ]. Previously, it was generally believed that the risk factors for NAFLD were excessive fructose intake, insulin resistance, and metabolic syndrome, followed by oxidative stress injury and endoplasmic reticulum stress, adipocytokine, mitochondrial dysfunction, and bisphenol A intake[ 13 , 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, the role of citrate mt in the early stage of ALI remains unknown. A previous study reported that citrate concentrations were positively associated with mitochondrial dysfunction in nonalcoholic fatty liver disease 33 . Thus, it is plausible that there is a link between citrate mt and mitochondrial dysfunction.…”
Section: Introductionmentioning
confidence: 89%